Poof! Cannabis Claims Disappear From DEA Website

As of February 13th, a document disseminating “misinformation” about cannabis was removed from the U.S. Drug Enforcement Administration’s website. “The DEA’s removal of these popular myths about cannabis from their website could mean the end of the Washington gridlock,” said Steph Sherer, executive director of Americans for Safe Access. Will the DEA make it reappear?

Read Full Article

Join The Big Boys, Aphria

Aphria Inc. (APH) has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX. APH must meet certain standards and customary conditions required by the TSX before the imposed 5/3/17 deadline. “Graduating to the TSX represents yet another important milestone for Aphria as we continue our successful journey as one of Canada’s leading cannabis companies,” Vic Neufeld, CEO of Aphria Inc.

Read Full Article

GWPH Q1 2017 Losses Less Than Expected

Canna-pharma giant, GW Pharmaceuticals, posted a Q1 2017 loss of $2.54 million. This is an improvement from the same period in 2016 where the company announced a $4.53 million loss. GWPH is banking on their lead cannabinoid product, Epidiolex. The company is also planning to introduce a candidate for autism spectrum disorders, which could be very exciting for the company.

Read Full Article

Canopy Growth Corp Closes its Acquisition of Metrum Health

A couple quick updates on one our favorite Canadian cannabis stocks. Canopy Growth Corp (TSX: WEED) now has a new ticker – changing to WEED from CGC. This is merely a cosmetic change. Shareholders don’t need to do anything. Secondly, Canopy has closed its acquisition of Metrum Health. The combined entity is the largest medical cannabis company in Canada. Shares of Metrum will no longer trade – shareholders will receive .7132 shares of Canopy per share of Metrum.

Read Full Article

GrowGeneration Expanding in High-Growth Colorado Market

GrowGeneration (OTC: GRWG) is a major supplier of retail and industrial hydroponic and organic gardening equipment. It operates in some of the fastest growing cannabis markets in the U.S. For example, it already owns and operates 8 stores in Colorado. GrowGen announced it is adding a 12the store, and its second in Denver – a 13,000 square foot facility that will also serve as the company’s new corporate headquarters. The location is killer –  more than 100 commercial growers operate in the same zip code. Keep your eye on GrowGen – this is a company I will be watching closely.

Read Full Article

Move over Boston Beer Company! AmeriCann (ACAN) is taking over.

AmeriCann, a Denver-based medical cannabis facility developer, has acquired a 53-acre property in Freetown, Massachusetts, formerly owned by brewing giant, Boston Beer Company (SAM). The property will be home to a 130,000 sqft cultivation and processing facility, as well as a 30,000 sqft research and development building.

Read Full Article

Mettrum Health Corp. (MT) will acquire Bodystream.

For the last two years, CEO of Mettrum, Michael Haines has been working with Bodystream, a network of medical cannabis clinics. After seeing Bodystream’s ability to scale while still maintaining professional integrity, Mettrum announced that they would acquire Bodystream and their 14 clinic locations across Ontario. Bodystream has approximately 6,000 active patients.

Read Full Article

Germany Makes Historic Move to Legalize Medical Cannabis

Big news for the cannabis industry. German parliament passed a law of Thursday that legalizes cannabis for medical purposes. As it stands only about 1,000 people in the entire country can legally consume medical cannabis. This law will expand that to potentially millions of new patients. The law is set to go into effect in March. This is great news for Canopy Growth Corp. (TSX: CGC). The largest medical marijuana company in Canada bought a German cannabis dispensary called MedCann for $8 million last year.

Read Full Article

Kush Bottles First-Quarter Home Run – Revenue up 44% from Last Year

Kush Bottles (OTC: KSHB) is one of our favorite cannabis stocks here at cannabis stocks trades. The U.S. cannabis company sells packaging materials to the U.S. cannabis industry. Kush reported first-quarter results on Jan 11. It was another quarter of strong growth for Kush. Revenue was up 44% from the same period last year to $2.5 million. Cash balance hit an all-time high of $2.0 million. Shares were mostly even on the news. Keep in mind, Kush is up 55% in the last year. Some of this good news has already been priced into shares. Looking forward, I’m expecting revenue to hit a new all-time high every quarter this year.

Read Full Article